Literature DB >> 10985331

Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera.

R Le Grand1, B Vaslin, J Larghero, O Neidez, H Thiebot, P Sellier, P Clayette, N Dereuddre-Bosquet, D Dormont.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10985331     DOI： 10.1097/00002030-200008180-00029

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection.

Authors:  H Thiebot; F Louache; B Vaslin; T de Revel; O Neildez; J Larghero; W Vainchenker; D Dormont; R Le Grand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion.

Authors:  Olivier Bourry; Abdelkrim Mannioui; Pierre Sellier; Camille Roucairol; Lucie Durand-Gasselin; Nathalie Dereuddre-Bosquet; Henri Benech; Pierre Roques; Roger Le Grand
Journal:  Retrovirology       Date:  2010-09-26       Impact factor: 4.602

3.  Susceptibilities of simian immunodeficiency virus to protease inhibitors.

Authors:  Angelica C Giuffre; Joanne Higgins; Robert W Buckheit; Thomas W North
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination.

Authors:  Pierre Sellier; Abdelkrim Mannioui; Olivier Bourry; Nathalie Dereuddre-Bosquet; Benoit Delache; Patricia Brochard; Julien Calvo; Sophie Prévot; Pierre Roques
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

5.  CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.

Authors:  Koen K A Van Rompay; Raman P Singh; Bapi Pahar; Donald L Sodora; Casey Wingfield; Jonathan R Lawson; Marta L Marthas; Norbert Bischofberger
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy.

Authors:  Kadija Benlhassan-Chahour; Claude Penit; Vincent Dioszeghy; Florence Vasseur; Geneviève Janvier; Yves Rivière; Nathalie Dereuddre-Bosquet; Dominique Dormont; Roger Le Grand; Bruno Vaslin
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.

Authors:  Marina Moreau; Anna Le Tortorec; Claire Deleage; Charles Brown; Hélène Denis; Anne-Pascale Satie; Olivier Bourry; Nathalie Deureuddre-Bosquet; Pierre Roques; Roger Le Grand; Nathalie Dejucq-Rainsford
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

8.  Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention.

Authors:  Peter Emau; Yonghou Jiang; Michael B Agy; Baoping Tian; Girma Bekele; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2006-11-28       Impact factor: 2.250

Review 9.  Current perspectives in HIV post-exposure prophylaxis.

Authors:  Binta Sultan; Paul Benn; Laura Waters
Journal:  HIV AIDS (Auckl)       Date:  2014-10-24

10.  Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques.

Authors:  Wei Wang; Nan Yao; Zhe Cong; Hong Jiang; Chuan Qin; Qiang Wei
Journal:  AIDS Res Ther       Date:  2014-03-04       Impact factor: 2.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.